Accolade Is Latest To Join Health Service IPO Bandwagon

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

To launch a successful IPO in the current market environment, it seems to help to be a fast-growing health care services provider.

Shares of One Medical, a provider of primary care clinics and telemedicine, closed up nearly 60 percent in first-day trading a month ago. Since then, it’s largely held on to those gains.

Progyny, a benefits management focusing on fertility, meanwhile, has seen its shares roughly double from its initial offer price back in October. While the broader markets have swooned, Progyny has held strong.

Now, another well-funded health service company is betting investor enthusiasm for the space will trump market skittishness. Accolade, a service provider that serves as a kind of go-between for consumers, employers and health insurance companies, is seeking to raise up to $100 million in an IPO, according to a prospectus filed late Friday.

The ups and downs of IPOs

Like most venture-backed companies on the IPO path, Accolade is posting both strong growth and persistent losses. Its most recent financials are for the ninth-month period ending Nov. 30, for which it reported revenue of $88 million, and a net loss of $49 million. For the corresponding period a year earlier, revenue was $60 million, with the same net loss of $49 million. (Accolade operates on a fiscal year ending in February, so results for its last full fiscal year are not yet available.)

The company’s pitch to investors is that its platform will see continued large-scale adoption as health care plans and services become increasingly complicated for people to navigate. Its customers are primarily employers that deploy Accolade to provide employees and their families “a single place to turn for their health, healthcare, and benefits needs,” per the IPO prospectus.

Accolades core offerings includes a software platform backed by a support staff of health assistants and clinicians.

Headquartered in Seattle, with significant operations in the Philadelphia area, Accolade has raised $237 million in known funding since its founding in 2007. Key backers include Andreessen HorowitzComcast Ventures and Carrick Capital Partners.

Home of Science
Follow me

- Advertisement -




European Championships: Watch Charlotte Worthington’s second run in heat 2on August 11, 2022 at 1:33 pm

Watch GB's Charlotte Worthington's highest scoring run of the park BMX freestyle as she averages 82.30 to finish first in heat 2 at the...

What will happen to energy bills and mortgages? Upcoming dates to be aware ofon August 24, 2022 at 11:30 pm

Dates to look out for over the next few months that might have an impact on your finances.Prices are shooting up and millions of...

Denis Law: Man Utd and Scotland legend diagnosed with dementiaon August 19, 2021 at 11:16 am

Scotland legend and former Manchester United forward Denis Law is diagnosed with dementia.Law, 81, who says he has Alzheimer's and vascular dementia, is the...

Ings scores on return as Saints seal comeback win over Burnleyon April 4, 2021 at 2:20 pm

Southampton fight back from 2-0 down to beat Burnley and claim a crucial three points in the battle for Premier League survival.Southampton fight back...

Covid in Wales: ‘Lessons to learn’ on anniversary of first caseon February 28, 2021 at 4:46 pm

Health Minister reflects on the pandemic response, a year on from the first reported case in Wales.Data published by Public Health Wales on Saturday...
Home of Science
Follow me